Randomized-controlled Trial of Yoga for Ulcerative Colitis

September 22, 2015 updated by: Holger Cramer, Universität Duisburg-Essen
The aim of this randomized trial is to investigate the effects of a 12-week yoga intervention compared to self-care on quality of life, stress, psychological health, and physiological parameters in 77 patients with ulcerative colitis.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Essen, Germany, 45276
        • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ulcerative colitis (clinical, endoscopic and histological diagnosis)
  • Disease duration at least 12 months
  • Clinical remission for at least 4 weeks and less than 12 months
  • CAI < 5
  • IBDQ < 170
  • Physical and mental ability to perform yoga
  • No regular practice of yoga or Pilates in the previous 12 months

Exclusion Criteria:

  • Clinically active disease (CAI > 4 Rachmilewitz)
  • Complete resection of the colon
  • Acute, infectious or chronic active ulcerative colitis
  • Severe disease precluding yoga practice
  • Malignancy with a disease-free survival < 5 years except curatively treated basalioma of the skin
  • Alcohol or drug abuse
  • Dementia
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Yoga
12-week Hatha Yoga intervention 90 minutes once a week
ACTIVE_COMPARATOR: Self-care
Self-care books are provided for self-directed use
Other Names:
  • Self-care book

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-specific quality of life
Time Frame: 3 months
Inflammatory Bowel Disease Questionnaire (IBDQ)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-specific quality of life
Time Frame: 6 months
Inflammatory Bowel Disease Questionnaire (IBDQ)
6 months
Generic quality of life
Time Frame: 3 months
36-Item Short Form Health Survey (SF-36)
3 months
Generic quality of life
Time Frame: 6 months
36-Item Short Form Health Survey (SF-36)
6 months
Anxiety/depression
Time Frame: 3 months
Hospital Anxiety and Depresion Scale (HADS)
3 months
Anxiety/depression
Time Frame: 6 months
Hospital Anxiety and Depresion Scale (HADS)
6 months
Subjective stress
Time Frame: 3 months
Perceived Stress Scale (PSS)
3 months
Subjective stress
Time Frame: 6 months
Perceived Stress Scale (PSS)
6 months
Subjective stress
Time Frame: 3 months
Perceived Stress Questionnaire (PSQ)
3 months
Subjective stress
Time Frame: 6 months
Perceived Stress Questionnaire (PSQ)
6 months
Positive/negative affect
Time Frame: 3 months
Positive and Negative Affect Schedule (PANAS)
3 months
Positive/negative affect
Time Frame: 6 months
Positive and Negative Affect Schedule (PANAS)
6 months
Body awareness
Time Frame: 3 months
Body Awareness Questionnaire (BAQ)
3 months
Body awareness
Time Frame: 6 months
Body Awareness Questionnaire (BAQ)
6 months
Body responsiveness
Time Frame: 3 months
Body Responsiveness Scale (BRS)
3 months
Body responsiveness
Time Frame: 6 months
Body Responsiveness Scale (BRS)
6 months
Self-efficacy
Time Frame: 3 months
General Self-Efficacy Scale
3 months
Self-efficacy
Time Frame: 6 months
General Self-Efficacy Scale
6 months
C-reactive protein
Time Frame: 3 months
C-reactive protein
3 months
C-reactive protein
Time Frame: 6 months
C-reactive protein
6 months
Blood sedimentation rate
Time Frame: 3 months
Blood sedimentation rate
3 months
Blood sedimentation rate
Time Frame: 6 months
Blood sedimentation rate
6 months
Faecal calprotectin
Time Frame: 3 months
Faecal calprotectin
3 months
Faecal calprotectin
Time Frame: 6 months
Faecal calprotectin
6 months
Faecal lactoferrin
Time Frame: 3 months
Faecal lactoferrin
3 months
Faecal lactoferrin
Time Frame: 6 months
Faecal lactoferrin
6 months
Faecel PMN-elastase
Time Frame: 3 months
Faecel PMN-elastase
3 months
Faecel PMN-elastase
Time Frame: 6 months
Faecel PMN-elastase
6 months
Disease activity
Time Frame: 3 months
Clinical Activity Index (CAI-Rachmilewitz)
3 months
Disease activity
Time Frame: 6 months
Clinical Activity Index (CAI-Rachmilewitz)
6 months
Salivary cortisol level
Time Frame: 3 months
Salivary cortisol level - cortisol awakening response
3 months
Steroid sensitivity
Time Frame: 3 months
Steroid sensitivity (IC50)
3 months
Andrenergic sensitivity
Time Frame: 3 months
Andrenergic sensitivity (IC50)
3 months
Cholinergic sensitivity
Time Frame: 3 months
Cholinergic sensitivity (IC50)
3 months
Safety
Time Frame: 3 months
Number of patients with adverse events/serious adverse events
3 months
Safety
Time Frame: 6 months
Number of patients with adverse events/serious adverse events
6 months
Hemogram
Time Frame: 3 months
Hemogram
3 months
Hemogram
Time Frame: 6 months
Hemogram
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: 3 months
Intervention adherence (number of sessions attended and home practice diary)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Holger Cramer, PhD, Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany
  • Study Director: Jost Langhorst, MD, Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (ACTUAL)

May 1, 2015

Study Completion (ACTUAL)

August 1, 2015

Study Registration Dates

First Submitted

January 21, 2014

First Submitted That Met QC Criteria

January 21, 2014

First Posted (ESTIMATE)

January 23, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

September 23, 2015

Last Update Submitted That Met QC Criteria

September 22, 2015

Last Verified

September 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colitis, Ulcerative

Clinical Trials on Yoga

Subscribe